Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy von Knight, Jennifer M., Szabo, Aniko, Arapi, Igli, Wu, Ruizhe, Emmrich, Amanda, Hackett, Edward, Sauber, Garrett, Yim, Sharon, Johnson, Bryon, Hari, Parameswaran, Schneider, Dina, Dropulic, Boro, Cusatis, Rachel N., Cole, Steve W., Hillard, Cecilia J., Shah, Nirav N.

Volltext

Quality of Life, Tryptophan Metabolites, and Neurotoxicity Assessments of Patients with Relapsed or Refractory B Cell Malignancies Undergoing CAR 20/19 - T Cell Therapy von Knight, Jennifer M, Arapi, Igli, Szabo, Aniko, Yim, Sharon, Sauber, Garrett, Hillard, Cecilia, Hari, Parameswaran, Shah, Nirav N.

Volltext

Multicenter Analysis of Transport Destinations for Pediatric Prehospital Patients von Lerner, E. Brooke, Studnek, Jonathan R., Fumo, Nicole, Banerjee, Anjishnu, Arapi, Igli, Browne, Lorin R., Ostermayer, Daniel G., Reynolds, Stacy, Shah, Manish I., Mistry, Rakesh

Volltext

Utilization of somatic comprehensive genomic profiling (CGP) to identify patients (pts) with pancreatic cancer (PC) that harbor germline DNA damage repair (DDR) gene alterations von Lasowski, Matthew, Stachowiak, Samantha, Arapi, Igli, Dua, Kulwinder, Khan, Abdul H., Hall, William Adrian, Erickson, Beth, Tsai, Susan, Christians, Kathleen K., Evans, Douglas B., Urrutia, Raul, Ritch, Paul S., Kamgar, Mandana, Thomas, James P., George, Ben

Volltext

Impact of CDKN2A/b status in pancreatic cancer (PC) von Annunzio, Kaitlin, Griffiths, Claire, Arapi, Igli, Lasowski, Matthew, Singavi, Arun K., Dua, Kulwinder, Khan, Abdul H., Ritch, Paul S., Kamgar, Mandana, Thomas, James P., Hall, William Adrian, Erickson, Beth, Tsai, Susan, Christians, Kathleen K., Evans, Douglas B., Urrutia, Raul, Szabo, Aniko, George, Ben

Volltext